AVANIR PHARMACEUTICALS, INC. 4/A SEC Filings

Filed On	Filing
19 Dec 2012	Form 4/A: Katkin Keith, Director Received 190,125 shares by exercise or conversion ($138K) · Received 220,500 shares as a grant or award · Granted 225,000 Stock Option (right to buy)
02 Mar 2010	Form 4/A: Mathews Charles, Director Received 40,000 shares as a grant or award
11 Jan 2010	Form 4/A: Katkin Keith, Director Gave up 51,557 shares to cover exercise price or tax ($102K) · Sold 20,000 shares ($38K) · Sold 15,025 shares ($29.3K)
11 Jan 2010	Form 4/A: Kaye Randall, Sr. VP, Chief Medical Officer Gave up 28,079 shares to cover exercise price or tax ($55.3K)
17 Dec 2007	Form 4/A: Kaye Randall, Chief Medical Officer Received 107,143 shares as a grant or award
08 Jun 2006	Form 4/A: Silverstein Jonathan, Director Disposed of 629,121 shares (Other Transaction) ($6.16M) · Acquired 348 shares (Other Transaction) ($3.41K)
05 Jun 2006	Form 4/A: Orbimed Advisors Llc, Director and 2 others Disposed of 629,121 shares (Other Transaction) ($6.16M)

Comments